CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Non Animal Origin Squalene For High-Risk Applications

  Explore an ethical and sustainable alternative to shark-derived squalene that is backed by robust data to deliver identical performance in vaccine formulations without environmental compromise.

• Solutions For CQA Analysis Of IVT mRNA-Based Biotherapeutics

  Discover new innovative solutions for mRNA analysis, enhancing accuracy and efficiency in IVT mRNA workflows, including advanced technologies and methodologies to optimize your research and development processes.

• Automated Manufacturing Of CD34-Enriched Cell Products

  See how this streamlined approach produces high-quality CD34+ cell products from cryopreserved apheresis material, integrating thawing, washing, and enrichment into a single automated workflow.

• Sample Clean-Up After N-Linked Glycan Release And Labeling

  Glycan profiling starts with effective clean-up. See how comparable recovery across key labeled glycans and sialylated glycan groups can support confident analysis while helping labs manage costs.

• Enhancing AAV Production Performance And Economics

  Enzymatically produced dbDNA offers safer, faster, and more scalable AAV manufacturing by reducing costs, improving full capsid yields, and enabling high‑fidelity, bacteria‑free DNA production.

• Scalability From 5L To 50L Using The DynaDrive Single-Use Bioreactor

  Maintaining a consistent bioprocess when scaling from 5 L to 50 L is achievable. This study shows how to successfully scale processes while maintaining cell density, viability, and protein production.

• Why RWD Strategy Can't Wait With Price, Value And Evidence Pressures Everywhere

  Overcome pricing pressures and reimbursement delays by integrating real-world evidence early in development to align clinical outcomes with payer demands and accelerate patient access.

• Biocompatibility Studies On CHO Cell Culture In X-ray Irradiated BioBLU® Single-Use Bioreactors

  In cell culture, the leakage of toxic or inhibitory chemicals from single-use bioreactors has become a growing concern. Explore recommendations for leachable studies.

• Enrichment Of Human CD4+ And CD8+ Antigen-Specific T Cells

  A fully automated workflow streamlines cell processing, labeling, and magnetic separation. Learn how automation supports reproducible manufacturing of virus- and cancer-targeted cellular products.

• Systemic Modularity: A Roadmap To Flexible, Efficient Biopharmaceutical Manufacturing

  Modernizing biomanufacturing requires shifting from rigid, custom setups toward modular automation, data-rich sensors, and plug-and-produce operations.